FTISADTSK

• Target:

  Drug Metabolite

• Related Pathways:

  Metabolism

• Bioactivity:

  FTISADTSK is an endogenous stable signature peptide derived from Trastuzumab, accurately assessed using selected reaction monitoring (SRM) .

• Smiles:

  CC[C@H] (C) [C@H] (NC (=O) [C@@H] (NC (=O) [C@@H] (N) Cc1ccccc1) [C@@H] (C) O) C (=O) N[C@@H] (CO) C (=O) N[C@@H] (C) C (=O) N[C@@H] (CC (O) =O) C (=O) N[C@@H] ([C@@H] (C) O) C (=O) N[C@@H] (CO) C (=O) N[C@@H] (CCCCN) C (O) =O

• Molecular Formula:

  C42H68N10O16

• Molecular Weight:

  969.06

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1431957-73-1